N. Anderson

Apoptosis and its clinical significance for bladder cancer therapy

P. Keane, K. Williamson, A. Irvine, 1999, BJU international.

Antisense Bcl–2 Oligonucleotide Uptake in Human Transitional Cell Carcinoma

P. Hamilton, P. Keane, D. Harkin, 2001, European Urology.

The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria

John V Lamont, Joe M O'Sullivan, P. Hamilton, 2012, Cancer.

Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data

F. Emmert-Streib, D. O’Rourke, R. de Matos Simoes, 2013, BMC Medicine.

Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific

M. Kurth, D. O’Rourke, J. Lamont, 2022, Frontiers in Oncology.